Lemaitre Vascular (LMAT) Current Assets (2010 - 2026)
Lemaitre Vascular's (LMAT) quarterly Current Assets came in at $488.3 million in Q2 2026, up 13.52% year-over-year from $430.1 million in Q2 2025, and up 2.19% quarter-over-quarter from $477.8 million in Q1 2026.
Analysis
Lemaitre Vascular (LMAT) Current Assets (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Current Assets for 17 consecutive years, with $488.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Current Assets rose 13.52% year-over-year to $488.3 million in Q2 2026; TTM through Jun 2026 was $488.3 million, a 13.52% increase from a year earlier, with the FY2025 full-year figure at $468.2 million, up 16.42% from the prior year.
- Current Assets was $488.3 million for Q2 2026 at Lemaitre Vascular, up from $477.8 million in the prior quarter.
- Over five years, Current Assets peaked at $488.3 million in Q2 2026 and troughed at $141.4 million in Q1 2022.
- A 5-year average of $282.8 million and a median of $207.9 million in 2024 frame the typical range for Current Assets.
- Across the five-year window, Current Assets jumped 106.68% in 2024 and advanced 13.52% in 2026, its largest moves.
- Over 5 years, Current Assets stood at $161.7 million in 2022, then advanced by 20.32% to $194.6 million in 2023, then surged by 106.68% to $402.2 million in 2024, then increased by 16.42% to $468.2 million in 2025, then advanced by 4.29% to $488.3 million in 2026.
- The last three Current Assets figures came in at $488.3 million (Q2 2026), $477.8 million (Q1 2026), and $468.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 24.52 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 9.54 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 24.39 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 14.42 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 7.97 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 6.82 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 6.62 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 4.09 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 2.45 Bn |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn | 488.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 488.30 Mn |
| Mar 31, 2026 | 477.82 Mn |
| Dec 31, 2025 | 468.23 Mn |
| Sep 30, 2025 | 452.03 Mn |
| Jun 30, 2025 | 430.13 Mn |
| Mar 31, 2025 | 408.11 Mn |
| Dec 31, 2024 | 402.19 Mn |
| Sep 30, 2024 | 227.12 Mn |
| Jun 30, 2024 | 212.81 Mn |
| Mar 31, 2024 | 202.96 Mn |
| Dec 31, 2023 | 194.60 Mn |
| Sep 30, 2023 | 182.18 Mn |
| Jun 30, 2023 | 174.49 Mn |
| Mar 31, 2023 | 164.77 Mn |
| Dec 31, 2022 | 161.73 Mn |
| Sep 30, 2022 | 153.14 Mn |
| Jun 30, 2022 | 148.49 Mn |
| Mar 31, 2022 | 141.41 Mn |
| Dec 31, 2021 | 139.88 Mn |
| Sep 30, 2021 | 134.02 Mn |